Yan Junjie, the billionaire founder, chairman and CEO of Chinese AI model developer MiniMax Group, has seen his fortune more than double to $7.8 billion on Forbes' World’s Real-Time Billionaires List ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Threat actors abused trusted Trivy distribution channels to inject credential‑stealing malware into CI/CD pipelines worldwide ...
MiniMax shares surged after revenue beat expectations in its first set of results following its listing. Shares of the Chinese artificial-intelligence company rose 18% to 884.00 Hong Kong dollars, or ...
MiniMax Group Inc. designs and develops an artificial intelligence (AI) foundation model. The company's platform offers a wide range of modalities, including text, audio, images, video, and music. The ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results